The US Endovascular Treatment Devices market is also influenced by the growing adoption of minimally invasive vascular procedures in outpatient and ambulatory settings. Expanding procedural capabilities are creating demand for compact, efficient, and clinically versatile endovascular technologies.

The Endovascular Treatment Devices Market size is projected to reach US$ 7.41 Billion by 2034 from US$ 3.34 Billion in 2025, registering a CAGR of 9.26% during 2026–2034. Endovascular treatment devices are used in minimally invasive procedures to diagnose and treat vascular conditions through catheter-based approaches. The market includes technologies such as stent grafts, embolization devices, thrombectomy systems, angioplasty devices, and other vascular intervention products. Increasing adoption of minimally invasive vascular procedures, rising cardiovascular and peripheral vascular disease burden, and continued advances in catheter-based technologies are supporting market growth.

What is driving the market?

The increasing adoption of minimally invasive vascular interventions and technological advances in endovascular treatment are major factors driving the Endovascular Treatment Devices Market.

Endovascular procedures allow physicians to treat several vascular conditions through catheter-based approaches rather than conventional open surgery. Growing clinical preference for less invasive treatment options is supporting the adoption of endovascular devices across hospitals and specialized vascular centers.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPRE00003734

The rising burden of cardiovascular and peripheral vascular diseases is another important market driver. Conditions affecting arteries and blood vessels can require interventions such as angioplasty, stenting, thrombectomy, embolization, and aneurysm repair, creating sustained demand for specialized devices.

Technological innovation is further expanding the capabilities of endovascular treatment. Improvements in stent design, delivery systems, guidewires, catheters, embolization technologies, and thrombectomy devices are enabling physicians to address increasingly complex vascular conditions.

The growing availability of specialized vascular centers and improvements in physician expertise are also supporting market development. Increased adoption of image-guided interventions allows healthcare providers to perform complex procedures with greater procedural control and visualization.

Which region leads?

North America represents a significant region in the Endovascular Treatment Devices Market, supported by advanced healthcare infrastructure, established interventional vascular services, and strong adoption of minimally invasive technologies.

The US is an important market due to its extensive network of hospitals, vascular centers, and interventional specialists. Demand for advanced endovascular technologies is supported by the high volume of cardiovascular and vascular procedures and continued investments in medical technology.

Europe also represents a significant market, supported by established healthcare systems and increasing adoption of catheter-based vascular interventions. Improvements in minimally invasive treatment capabilities are contributing to the use of advanced endovascular devices.

Asia Pacific offers considerable growth opportunities as healthcare infrastructure expands and access to specialized vascular treatment improves. Increasing healthcare expenditure, growing awareness of minimally invasive procedures, and investments in hospitals and interventional centers are supporting market development.

Latin America and the Middle East and Africa are also developing markets. Expansion of healthcare facilities, increasing availability of advanced imaging systems, and improving access to vascular interventions are creating additional opportunities.

Which segment leads?

Stent grafts, thrombectomy systems, angioplasty devices, and other catheter-based vascular intervention technologies represent important product areas within the Endovascular Treatment Devices Market.

The market can be segmented by product, application, end user, and geography. Stent and stent-graft technologies are widely used in the management of vascular obstruction and aneurysmal disease, while thrombectomy devices are increasingly used in procedures designed to remove blood clots.

Peripheral vascular interventions represent an important application area, with devices used to restore or maintain blood flow in affected vessels. Endovascular aneurysm repair is another major application supported by advances in stent-graft technology and delivery systems.

Neurovascular interventions also contribute to demand for specialized endovascular technologies, particularly devices designed for clot removal and vessel treatment.

Hospitals and specialized vascular centers remain major end users because they conduct complex image-guided procedures. Ambulatory and specialty intervention facilities are also contributing to demand as minimally invasive treatment expands across healthcare settings.

Which companies are prominent?

Leading companies are focusing on device innovation, delivery-system improvements, procedural precision, and expansion of minimally invasive treatment applications to strengthen their positions in the Endovascular Treatment Devices Market.

• Cardinal Health
• Boston Scientific
• Endospan
• Getinge AB
• InspireMD
• Japan Lifeline
• Lombard Medical Technologies
• Medtronic
• Penumbra
• Terumo Corporation

Competition is influenced by device performance, procedural flexibility, delivery-system design, clinical utility, and compatibility with existing interventional workflows. Manufacturers are developing products aimed at treating increasingly complex vascular conditions while improving procedural efficiency.

Strategic collaborations, product launches, clinical development, and geographic expansion are also important competitive strategies. Companies are increasingly emphasizing technologies that provide physicians with greater control during minimally invasive vascular procedures.

What is changing in 2026?

In 2026, the Endovascular Treatment Devices Market is increasingly shifting toward advanced catheter technologies, improved device deliverability, image-guided procedures, and technologies designed for complex vascular interventions.

Advances in catheter and delivery-system design are allowing physicians to navigate challenging vascular anatomy and access treatment sites through minimally invasive approaches. Smaller profiles, improved flexibility, and enhanced maneuverability are important areas of product development.

Thrombectomy technologies are also evolving as clinicians seek more effective approaches for removing blood clots from affected vessels. Improvements in device design and procedural techniques are expanding the role of endovascular intervention in selected vascular and neurovascular conditions.

Imaging and navigation technologies are becoming increasingly important for procedural planning and execution. Better visualization can support device positioning and help clinicians manage complex interventions.

There is also growing interest in personalized endovascular treatment. Device selection and procedural planning can increasingly account for vessel anatomy, lesion characteristics, and patient-specific clinical factors.

What are the major investment opportunities?

Major investment opportunities are emerging in thrombectomy systems, advanced stent grafts, peripheral vascular devices, neurovascular intervention technologies, and next-generation catheter-based treatment platforms.

Thrombectomy represents an important area of innovation as healthcare systems expand access to minimally invasive clot-removal procedures. Companies developing more flexible, efficient, and clinically adaptable thrombectomy technologies may find opportunities across vascular and neurovascular applications.

Advanced stent-graft technologies also offer opportunities as physicians manage increasingly complex aneurysmal and vascular conditions. Improvements in deployment accuracy, flexibility, durability, and delivery systems can support further adoption.

Peripheral vascular intervention provides another area of opportunity, particularly as healthcare providers seek less invasive alternatives for selected patients with vascular disease. Drug-delivery technologies, angioplasty systems, stents, and specialized crossing devices can contribute to this expanding treatment landscape.

Emerging markets provide additional opportunities as hospitals invest in catheterization laboratories, advanced imaging infrastructure, and specialist training. Expansion of interventional vascular services can support long-term demand for endovascular treatment devices.

Related Reports:

Interventional Cardiology Devices Market Share, Growth & Forecast by 2034

Endovascular Stent Grafts Market Size, Share & Trends by 2034

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]  
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish